Stocks / GSK (LSE: GSK) / LSE:GSK (GSK)About GSKGlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000. Summary Profile Price History Financials Peer Comparison Share Info Performance Dividends Events GSK (LSE: GSK) Latest News Investing Articles At £16.70, I think this FTSE 100 stock could be 24% undervalued! 19 February, 2024 | Royston Wild The GSK share price offers sector-leading value at current prices. Royston Wild explains why the FTSE 100 stock is on… Read more » Investing Articles 2 contrasting FTSE income stocks investors should consider snapping up! 15 February, 2024 | Sumayya Mansoor Income stocks paying dividends are an enticing prospect. Our writer breaks down two options for investors to take a closer… Read more » Investing Articles £10,000 in savings? I’d aim for £633k in FTSE 100 shares and £25k a year of passive income 13 February, 2024 | Royston Wild I'm aiming for a blistering second income by prioritising investment in FTSE 100 shares. Here's how this strategy could supercharge… Read more » Investing Articles Is the GSK share price too cheap to ignore? 1 February, 2024 | Dylan Hood The GSK share price has risen 7% in 2024, but still looks cheap to me. This Fool takes a closer… Read more » Investing Articles Is biopharmaceutical company GSK worth buying as a high-income dividend stock? 1 February, 2024 | Kevin Godbold The GSK directors are guiding for a dividend rise this year. So does the almost 4% yield make it a… Read more » Investing Articles Is the GSK share price too low, after another strong set of results? 31 January, 2024 | Alan Oscroft The GSK share price has had a weak five years, and strong results for 2023 make me think the market… Read more » Investing Articles After GSK’s 11% share price rise, is it too late for me to buy more? 25 January, 2024 | Simon Watkins Despite GSK’s share price rising 11% in a year, there appears good value left in them, with a new growth… Read more » Investing Articles Just released: our 3 top income-focused stocks to buy before February [PREMIUM PICKS] 22 January, 2024 | Mark Rogers Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due… Read more » Investing Articles If I’d put £1,000 in GSK shares 6 months ago, here’s what I’d have now 12 January, 2024 | Dr. James Fox What's going on with GSK shares? The pharmaceutical giant has seen its share price surge in recent months. Dr James… Read more » Investing Articles 2 magnificent dividend stocks for recurrent income! 10 January, 2024 | Sumayya Mansoor Identifying dividend stocks for passive income isn’t easy. There are many things to consider but our writer reckons she’s found… Read more » Investing Articles One overlooked value stock I’d buy today and it’s not British American Tobacco 7 January, 2024 | Harvey Jones This FTSE 100 value stock is in need of a little love, after several years of poor performance. I think… Read more » Investing Articles 3 healthcare dividend stocks to consider for passive income in 2024 7 January, 2024 | Ben McPoland Our writer takes a look at three dividend stocks from the US and UK that could provide attractive passive income… Read more » ❮1…56789…❯
Investing Articles At £16.70, I think this FTSE 100 stock could be 24% undervalued! 19 February, 2024 | Royston Wild The GSK share price offers sector-leading value at current prices. Royston Wild explains why the FTSE 100 stock is on… Read more »
Investing Articles 2 contrasting FTSE income stocks investors should consider snapping up! 15 February, 2024 | Sumayya Mansoor Income stocks paying dividends are an enticing prospect. Our writer breaks down two options for investors to take a closer… Read more »
Investing Articles £10,000 in savings? I’d aim for £633k in FTSE 100 shares and £25k a year of passive income 13 February, 2024 | Royston Wild I'm aiming for a blistering second income by prioritising investment in FTSE 100 shares. Here's how this strategy could supercharge… Read more »
Investing Articles Is the GSK share price too cheap to ignore? 1 February, 2024 | Dylan Hood The GSK share price has risen 7% in 2024, but still looks cheap to me. This Fool takes a closer… Read more »
Investing Articles Is biopharmaceutical company GSK worth buying as a high-income dividend stock? 1 February, 2024 | Kevin Godbold The GSK directors are guiding for a dividend rise this year. So does the almost 4% yield make it a… Read more »
Investing Articles Is the GSK share price too low, after another strong set of results? 31 January, 2024 | Alan Oscroft The GSK share price has had a weak five years, and strong results for 2023 make me think the market… Read more »
Investing Articles After GSK’s 11% share price rise, is it too late for me to buy more? 25 January, 2024 | Simon Watkins Despite GSK’s share price rising 11% in a year, there appears good value left in them, with a new growth… Read more »
Investing Articles Just released: our 3 top income-focused stocks to buy before February [PREMIUM PICKS] 22 January, 2024 | Mark Rogers Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due… Read more »
Investing Articles If I’d put £1,000 in GSK shares 6 months ago, here’s what I’d have now 12 January, 2024 | Dr. James Fox What's going on with GSK shares? The pharmaceutical giant has seen its share price surge in recent months. Dr James… Read more »
Investing Articles 2 magnificent dividend stocks for recurrent income! 10 January, 2024 | Sumayya Mansoor Identifying dividend stocks for passive income isn’t easy. There are many things to consider but our writer reckons she’s found… Read more »
Investing Articles One overlooked value stock I’d buy today and it’s not British American Tobacco 7 January, 2024 | Harvey Jones This FTSE 100 value stock is in need of a little love, after several years of poor performance. I think… Read more »
Investing Articles 3 healthcare dividend stocks to consider for passive income in 2024 7 January, 2024 | Ben McPoland Our writer takes a look at three dividend stocks from the US and UK that could provide attractive passive income… Read more »